 | Up a level |
Patsenker, Eleanora; Sachse, Philip; Chicca, Andrea; Gachet Otanez, Maria Salomé; Schneider, Vreni; Mattsson, Johan; Lanz, Christian; Worni, Mathias; De Gottardi, Andrea; Semmo, Mariam; Hampe, Jochen; Schafmayer, Clemens; Brenneisen, Rudolf Max; Gertsch, Jürg; Stickel, Felix; Semmo, Nasser (2015). Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation. International journal of molecular sciences, 16(4), pp. 7057-7076. MDPI 10.3390/ijms16047057
Stickel, Felix; Osterreicher, Christoph H; Halangk, Juliane; Berg, Thomas; Homann, Nils; Hellerbrand, Claus; Patsenker, Eleonora; Schneider, Vreni; Kolb, Armin; Friess, Helmut; Schuppan, Detlef; Puhl, Gero; Seitz, Helmut K; Leathart, Julian L B; Day, Christopher P (2008). No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease. Alcoholism: clinical and experimental research, 32(6), pp. 959-65. Oxford: Wiley-Blackwell 10.1111/j.1530-0277.2008.00654.x
Neef, M; Ledermann, M; Saegesser, H; Schneider, V; Reichen, J (2007). Corrigendum to "Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis"... Journal of hepatology, 47(2), p. 310. Amsterdam: Elsevier 10.1016/j.jhep.2007.06.003
Patsenker, Eleanora; Sachse, Philip; Mattsson, Johan; Lanz, Christian; Schneider, Vreni; Brenneisen, Rudolf Max; De Gottardi, Andrea; Dufour, Jean-François; Stickel, Felix; Semmo, Nasser (April 2014). Endocannabinoids Suppress Cytokine Secretion in HCV Infection (Unpublished). In: EASL International Liver Congress 2014. London, UK. 09.-13.04.2014.
